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Hepatitis B is an inflammatory disease of the liver caused due to an infection 
from the hepatitis B virus (HBV). This inflammatory liver disease can become 
chronic, causing liver cirrhosis, and then become cancerous. Hepatitis B 
vaccination process by injection. Hepatitis B antibodies can appear in 
response to Hepatitis B vaccination. The purpose of this study as an effort to 
decide the effectiveness of Hepatitis B vaccination by seeing whether active 
immunity has formed against infections caused by the Hepatitis B virus to 
Stikes Student Jenderal Ahmad Yani Cimahi. The research method used in 
this research is descriptive. Samples used in the study were 30 people who 
met the inclusion criteria. From the results of studies using the 
immunochromatographic method, all positive samples were found with 
hepatitis B antibodies. Based on the research can be concluded that the 
vaccination conducted on Stikes Jenderal Achmad Yani Cimahi has given 
effective results and has a protective titer to prevent hepatitis B virus infection 
that will attack his body. 
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INTRODUCTION  
Hepatitis B is a disease caused by the hepatitis B virus that can cause 
inflammation of the liver. This chronic case of liver inflammation can develop into liver 
cancer and cirrhosis of the liver.1 Results of the 2013 Basic Health Research (Riskesdas) 
the type of hepatitis that mostly attacks Indonesian people is hepatitis B with a percentage 
of 21.8%. Efforts to prevent hepatitis B infection are by vaccinating Hepatitis B.2,3. 
Giving the hepatitis B vaccine by injection to healthy people will produce Anti-
HBs antibodies as much as 95% in response to hepatitis B vaccination. Anti-HBs is an 
antibody obtained from the hepatitis b virus and is an active immunity for the body.4 The 
success of the vaccination is known from the Anti-Hbs titer examination. The number of 
antibody titers can decrease in proportion to immunization interval, at older ages with 
longer immunization distances, Anti-HBs titers will decrease. Giving vaccines to infants 
and children will produce a good response, even though the dose given is smaller than 
the adult dose. Anti-HBs antibodies estimated to last for 5 years in the 
body.5 Effectivity the hepatitis B vaccine received by a person be determined by 
measuring the Anti-HBs titter in the body after vaccination.1 Anti-HBs titers that can give 
immunity are more than 10 mIU/ml.3 
Hepatitis B vaccination is given to babies aged 4 weeks at the first dose and 
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needs to give during adulthood, especially for health workers.6,7 Health workers have a 
high risk of hepatitis B transmission. Horizontal transmission of hepatitis B through blood 
transfusions, body fluids, contaminated syringes, razors, tattoos, and organ transplants.8,9 
The profession as a medical laboratory technical analyst is a part of the health workforce 
that has a lot to do with examining body fluids, syringes and blood which has a high risk, 
so it is necessary to administer hepatitis B vaccine at an educational level with the aim of 
being able to form Anti-HBs before working in the laboratory.10 
Anti-HBs laboratory tests by immunology using immunochromatography (ICT) 
methods can show the effectiveness of vaccinations received by a person. The measure 
to decide the effectiveness of the hepatitis B vaccine is to decide anti-HBs, so we need to 
know the effectiveness of vaccines in health analyst students who are vaccinated as a 
form of prevention against hepatitis B. The results of this study be provided anti-
HBs information to health analyst students who have vaccinated whether or not to need 
the hepatitis B vaccine again or not. 
 
MATERIALS AND METHODS  
 This research is a descriptive study that aims to decide Hepatitis B vaccination in 
Stikes Jenderal Achmad Yani Cimahi students. The population used in this study were 
students of Stikes Jenderal Achmad Yani Cimahi. The sampling technique used in this 
research is purposive sampling where selected sample was 30 students at level 1 of 
technology laboratory medic Stikes Jenderal Achmad Yani Cimahi with the inclusion 
criteria having vaccinated hepatitis B 3 times. 
 The researchers took 3 ml of student vein blood, then made serum by 
centrifugation for 15 minutes at 3000 rpm. Anti-HBs examination on serum samples using 
an immunochromatography test kit then the results comparing with controls. 
 
A. Instrument and material  
The instruments used in the study are centrifuge (Gemmy), Micropipette (Thermo 
scientific), and torniquet (BD). Materials used in research is aquadest (Amidis), alcohol, 
alcohol swab, syiringe (Terumo), plester, ICT Kit (Wondfo), vaccutainer tube (BD), 
polypropylene tube 1.5 ml (Eppendorf), Yellow tip (Thermo), Blue tip (Thermo), mask 
(Sensi) 
 
B. Procedure 
1. Perform venepuncture as follows 11 :  
Apply alcohol swab for 30 seconds and allow to dry completely (30 seconds). 
Alcohol is preferable to povidone-iodine, because blood contaminated with 
povidone-iodine may falsely increase levels of potassium, phosphorus, or uric acid 
in laboratory test results. Applying firm but with gentle pressure, start from the 
center of the venepuncture site and work downward and outwards to cover an 
area of 2 cm or more. Allowing the area to dry, if failed to allow enough contact 
time increases the risk of contamination. Not to touch the cleaned site; in 
particular, nothing places a finger over the vein to guide the shaft of the exposed 
needle. It the site is touched, repeat the disinfection. Anchor the vein by holding 
the patient’s arm and placing a thumb BELOW the venepuncture site. Asking the 
patient to form a fist so the veins are more prominent. Enter the vein swiftly at a 
30-degree angle or less, and continue to introduce the needle along the vein at the 
easiest angle of entry. Once sufficient blood has been collected, release the 
tourniquet before withdrawing the needle. Some guidelines suggest removing the 
tourniquet as soon as blood flow is established, and always before it has been in 
place for two minutes or more. Withdrawing the needle gently and apply gentle 
pressure to the site with clean gauze or dry cotton-wool ball. Ask the patient to 
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hold the gauze or cotton wool in place, with the arm extended and raised. Patient 
not to bend the arm, because doing so causes a haematoma. 
 
2. Perform serum as follows:  
 The blood in the vacuüm tube allows us to stand for 30 minutes at room 
temperature. Samples centrifuges for 15 minutes at 3000 rpm then the serum 
transfer to 1.5 ml polypropylene tubes. 
 
3. Anti-HBs Test 12 
Anti-HBs Test using Imunochromatography (ICT) method. Wondfo 
One Step HBsAb Serum/Plasma Test Cassette is a rapid 
immunochromatographic test for the visual detection of hepatitis B virus 
surface antibody (HBsAb) in serum/plasma samples. When the 
specimen is added into the test device, the specimen is absorbed into 
the device by capillary action, mixes with the antigen conjugate, and 
flows across the pre-coated membrane. 
The device and specimen allowing to equilibrate to room 
temperature (10°C - 30°C) before testing. The testing device removed 
from the foil punch by tearing at the notch and place it on a level 
surface. The sample dropper held vertically and add four drops (80 µl- 
100 µl) of the specimen to the sample well. Read the results after 15 
minutes, and make sure not to read the results after 30 minutes. 
Interpretation of Anti HBs rapid test results showed in Figure 1.  
 
Figure 1. Interpretation of Anti HBs rapid test results 
(Source: Wondfo, 2019) 
 
Positive (+): rose-pink bands are visible in both the control region and the test 
region. A positive result indicates the concentration of HBsAb is equal to or higher 
than the detection limit of the test. 
 
Negative (-): a rose-pink band is visible in the control region. No color band 
appropriate test region. A negative result indicates that HBsAB is zero or below the 
detection limit of the test. 
 
Invalid: no visible band at all, or there is a visible band in the test region but not in 
the control region. Repeat with a new test kit. If the test still fails, please contact 
the distributor or the store, where you bought the product, with the lot number. 
 
Data Collection and Analysis Techniques 
Data collection through interviews before taking blood and then the results of 
laboratory tests conducted by the ICT method. Descriptive data analysis by looking 
at the relationship between hepatitis B vaccination and antibodies against hepatitis 
B in Stikes Jenderal Achmad Yani Cimahi's students. 
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RESULTS AND DISCUSSION  
In this study using a sample of 30 people. anti-HBs examination in this study uses 
the examination method that is immunochromatography (ICT) to decide the effectiveness 
of hepatitis B vaccination. The results of the examination see in table 1. 
 
Table 1. Results from HBsAb examination using Immunochromatography (ICT)  
NUMBER CODE  ICT RESULT 
1 APS Positive 
2 ESA Positive 
3 TIN Positive 
4 DL Positive 
5 VNA Positive 
6 YN Positive 
7 NMR Positive 
8 TA Positive 
9 VAR Positive 
10 ASF Positive 
11 SSQ Positive 
12 NHM Positive 
13 SI Positive 
14 TN Positive 
15 MIM Positive 
16 RPA Positive 
17 RS Positive 
18 RAH Positive 
19 MWD Positive 
20 RGH Positive 
21 AAS Positive 
22 A Positive 
23 ZP Positive 
24 SPA Positive 
25 VFR Positive 
26 GNR Positive 
27 NSS Positive 
28 EN Positive 
29 GL Positive 
30 NAF Positive 
 
 
Based on table 1, 30 samples stated positive results containing anti-HBs. Results are 
expressed as a percentage using the following formula: 
 
Positive Results (+) = Positive Sampel anti-HBs     x  100% 
 Total Sample   
         = 30     x  100%  
            30 
= 100%  
 
The study conduct at Stikes Jenderal Achmad Yani Cimahi with the criteria that 
respondents had vaccinated as much as 3 times. The research aims to detect anti-
HBs antibodies after vaccination. Detection of anti-HBs antibodies in serum in 
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respondents based on qualitative analysis using the immunochromatographic examination 
(ICT) method. Based on research conducted there were 30 samples found positive there 
are anti-HBs antibodies in the body with a percentage of 100%. Booster or natural 
infection can increase antigen reserves at the germinal center, as a trigger for increased 
humoral immune response in the form of plasma cells and B cells memory.13 The 
response to primary infection is the presence of plasma cells produced by B cells into 
plasma cells and memory cells in the germinal centers of lymphoid tissue, then plasma 
cells migrate to the bone marrow while memory cells circulate throughout the body. When 
memory cells circulate back into lymphoid tissue that has similar antigens, the cycle of 
differentiation into plasma cells takes place faster so that antibodies with higher affinity 
and numbers are produced.14 
The vaccine, which includes passive immunity, passive immunity may also be 
used as a preventive (prophylaxis) to boost the immune potential of those with 
compromised immunity or who anticipate future exposure to a particular pathogen, namely 
the hepatitis B virus entering the body.15 The vaccine content is an antigen that is 
weakened so that it does not cause a person to get sick but stimulates the body's immune 
system which is adaptive immune. to produce T lymphocytes and antibodies. Adaptive 
immune response has two types of immunity namely humoral immunity and cellular 
immunity, which mediate various components of the body's immune system to destroy 
disease-causing microorganisms that attack the body. Lymphocytes are one of the 
immune cells that have specific receptors for various antigens and are the key mediators 
of adaptive immunity Humoral immunity is found in B lymphocyte cells that produce 
antibodies. whereas in cellular immunity there are T lymphocyte cells associated with cells 
which will then look like they have an infection and cause mild symptoms, such as fever.16 
The vaccine makes immunity in our body by inserting attenuated antigen. This 
attenuated antigen does not cause a response such as disease because the vaccine can 
stimulate the body to produce T-lymphocytes and antibodies to form immunity in the body. 
mild symptoms, such as fever is one of the effects obtained after giving the vaccine. 
These mild symptoms should normally exist as a form of response the body is forming 
immunity. After the infection from this vaccine disappears, the body has T lymphocyte 
cells and B memory B cells that have the ability to remember if there are the same 
antigens that have invaded the body.17,18 
Healthy people who get the vaccine will induce humoral and cellular responses 
so that an immune response that is able to protect themselves from the disease is 
achieved without having to wait for the development of an active immune response.19 To 
make this response the vaccine must be given in several doses and in the presence 
of booster or repetition so that protective titter is obtained. Especially for public health and 
safety workers who are at risk of getting blood or body fluids where the vaccine is usually 
given as much as 2, 3 to 4 injections within a period of 1 to 6 months. Within a period of 
years, individuals who are at risk of HBV infection (most of the work) need to be given 
booster immunization until reaching an anti-HBs protective titer of at least 10 IU / L (in 
most countries) or 100 IU / L (in the UK)) . Anti-HBS titers are called protective titers if the 
titers reach above 10 mIU / mL. Some countries 100 mIU / mL anti-HBs levels have been 
retained with protective titer, to ensure that someone has received an immune response 
that is specific to anti-HBs.20 Giving hepatitis B vaccine as much as 3 doses will be 
achieved antibody titer> 10 IU, but in some people, around 10% in adults and 5% in 
children this is not achieved.13 
 
 
CONCLUSIONS  
Based on the results of 30 anti-HBs test samples using immunochromatography 
methods, it was found that a positive result was found to have anti-HBs antibodies in the 
body of Stikes General Achmad Yani Cimahi with a percentage of 100% 
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